In a multi-institutional cohort of myeloid sarcomas, NFE2 mutation prevalence is lower than previously reported
Tauangtham Anekpuritanang,Matthew M. Klairmont,Joel Gradowski,Kohei Hagiwara,Nathanael G. Bailey, Pranil Chandra,Yiwei Liu,Heather L. Mulder,John Easton,Jinghui Zhang, Michael G. Martin,Anna B. Owczarczyk,Jennifer B. Dunlap,Guang Fan,Richard D. Press,Philipp W. Raess Blood Advances(2021)
AI 理解论文
溯源树
样例